Variant report
Variant | esv3320830 |
---|---|
Chromosome Location | chr1:173083639-173084998 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs534845411 | chr1:173083661-173083662 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs546693426 | chr1:173083720-173083721 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs568204978 | chr1:173083766-173083767 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs532281922 | chr1:173083812-173083813 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs561017271 | chr1:173083816-173083817 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs556874901 | chr1:173083819-173083820 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs12758183 | chr1:173083844-173083845 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs182237571 | chr1:173083889-173083890 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs186962778 | chr1:173083900-173083901 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs537723177 | chr1:173083950-173083951 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs61826327 | chr1:173084007-173084008 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs111536586 | chr1:173084017-173084018 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs577008761 | chr1:173084077-173084078 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs12743990 | chr1:173084083-173084084 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs116423123 | chr1:173084089-173084090 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs373849113 | chr1:173084098-173084099 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs12406059 | chr1:173084169-173084170 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs532185663 | chr1:173084172-173084173 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs142824942 | chr1:173084204-173084205 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs34931839 | chr1:173084218-173084219 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs190651425 | chr1:173084242-173084243 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs182386966 | chr1:173084284-173084285 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs551718944 | chr1:173084309-173084310 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs151336719 | chr1:173084311-173084312 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs28488605 | chr1:173084314-173084315 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs12757847 | chr1:173084377-173084378 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs185473187 | chr1:173084433-173084434 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs528288826 | chr1:173084470-173084471 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs114702736 | chr1:173084560-173084561 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs147218719 | chr1:173084570-173084571 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs546856523 | chr1:173084574-173084575 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs568270002 | chr1:173084576-173084577 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs60750682 | chr1:173084600-173084601 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs76292126 | chr1:173084601-173084602 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs528934702 | chr1:173084606-173084607 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs182254031 | chr1:173084649-173084650 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs568801858 | chr1:173084654-173084655 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs539096449 | chr1:173084660-173084661 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs12088676 | chr1:173084661-173084662 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs570857451 | chr1:173084672-173084673 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs139633300 | chr1:173084704-173084705 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs187712740 | chr1:173084711-173084712 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs17300100 | chr1:173084744-173084745 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs534300278 | chr1:173084779-173084780 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs149908262 | chr1:173084823-173084824 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs76332009 | chr1:173084838-173084839 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs111463318 | chr1:173084840-173084841 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs545921329 | chr1:173084868-173084869 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs552325350 | chr1:173084916-173084917 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Liposarcoma | 21253554 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21183584 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Rett syndrome | 21593744 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Bladder cancer | 19088036 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Breast cancer | 21858162 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chordoma | 18071362 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Trisomy 5 syndrome | 21098271 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Breast cancer | 21611746 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Glioblastoma multiforme | 17369134 | CNVD |
Cancer | 17440070 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:173080400-173083800 | Enhancers | Primary B cells from cord blood | blood |
2 | chr1:173080400-173084000 | Enhancers | Primary monocytes fromperipheralblood | blood |
3 | chr1:173080600-173083800 | Enhancers | HUVEC | blood vessel |
4 | chr1:173081000-173083800 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
5 | chr1:173081200-173084000 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
6 | chr1:173081200-173084000 | Enhancers | NHEK | skin |
7 | chr1:173081600-173091200 | Weak transcription | NHDF-Ad | bronchial |
8 | chr1:173082400-173091200 | Weak transcription | NHLF | lung |
9 | chr1:173082800-173086400 | Weak transcription | Primary B cells from peripheral blood | blood |
10 | chr1:173082800-173091000 | Weak transcription | HSMM | muscle |
11 | chr1:173083600-173083800 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
12 | chr1:173083600-173083800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
13 | chr1:173083600-173083800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
14 | chr1:173083600-173084000 | Enhancers | Monocytes-CD14+_RO01746 | blood |
15 | chr1:173083600-173084400 | Enhancers | Fetal Intestine Large | intestine |
16 | chr1:173083800-173086400 | Weak transcription | Primary B cells from cord blood | blood |
17 | chr1:173083800-173086400 | Weak transcription | HUVEC | blood vessel |
18 | chr1:173084000-173085800 | Weak transcription | Primary monocytes fromperipheralblood | blood |
19 | chr1:173084000-173085800 | Weak transcription | Monocytes-CD14+_RO01746 | blood |
20 | chr1:173084400-173091000 | Weak transcription | Fetal Intestine Large | intestine |